Pembrolizumab in patients with programmed death ligand 1–positive advanced ovarian cancer: Analysis of KEYNOTE-028

出版年份 2018 全文链接

标题

作者

关键词

Gynecologic cancers, Immunotherapy, Clinical trials, PD-1, Pembrolizumab

出版物

Volume -, Issue -, Pages -

出版商

Elsevier BV

发表日期

2018-12-03

DOI

10.1016/j.ygyno.2018.11.017

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started